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Background: Neuropathic pain evoked by nerve injury is frequently accompanied by deterioration of emotional
behaviors, but the underlying signaling mechanisms remain elusive. Glutamate (Glu) is the major mediator of
excitatory synaptic transmission throughout the brain, and abnormal activity of the glutamatergic system has been
implicated in the pathophysiology of pain and associated emotional comorbidities. In this study we used the partial
sciatic nerve ligation (PSNL) model of neuropathic pain in rats to characterize the development of anxiety-like behavior,
the expression of glutamatergic receptors, and the phosphorylation of extracellular signal-regulated kinase (ERK) in the
hippocampus, the region that encodes memories related to emotions.
Results: We found that the mechanical withdrawal threshold was significantly reduced and an anxiety-like
behavior was increased as determined via open field tests and elevated plus-maze tests at 28 days after injury.
No significant differences were found in the ratio of sucrose preference and immobility time detected by
sucrose preference tests and forced swimming tests respectively, possibly due to the timing factor. The expression of
N-methyl-D-aspartate (NMDA) receptor subtypes NR1 and NR2B, but not NR2A, GluR1, or GluR2 (the main subtype of
the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid [AMPA] receptor) in the hippocampus of injured rats
was significantly reduced. Moreover, PSNL resulted in decreased phosphorylation of ERK1/2 in the hippocampus.
Intriguingly, treatment with D-serine (a co-agonist of NMDA receptor, 1 g/kg intraperitoneally) reduced the
anxiety-like behavior but not the mechanical hypersensitivity induced by PSNL.
Conclusions: PSNL can induce significant anxiety-like but not depression-like behavior, and trigger down-regulation of
NMDA but not AMPA receptors in the hippocampus at 28 days after injury.
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Pain is related to sensory and affective parameters and
accompanied by feelings of unpleasantness [1,2]. Chronic
neuropathic pain arising from a lesion or dysfunction
within the nervous system is a prevalent clinical problem
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unless otherwise stated.pain is associated with conditions such as anxiety and de-
pression [3,4]. Numerous studies have shown that pain-
related mood disorders affect the perception of pain and
reduce the pain threshold [5,6]. However, the underlying
mechanisms of pain- associated behaviors that arise from
the brain are poorly understood.
To date, human and animal studies have indicated that
supraspinal structures are involved in pain. In particular,
the hippocampus as a major part of the limbic system
has been the subject of research interest in recent years
because of its relation to the emotional component of
pain [7,8]. For example, one study found that emotional
abnormalities associated with chronic back pain areThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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hippocampus, and between the hippocampus and the
cortex [9]. Another study reported that the synaptic
plasticity in the hippocampus is involved in the neuro-
pathic pain condition based on the observation that
hippocampal long-term potentiation is impaired after
peripheral nerve injury [10]. The hippocampus also plays
a vital regulatory role in mood and depressive symptoms
in burning mouth syndrome, one form of chronic pain,
with increased gray matter volume (GMV) in the hippo-
campus and increased connectivity between bilateral
hippocampus/amygdala and medial prefrontal cortex
[11]. The optimal management of neuropathic pain in-
cluding the alleviation of anxiety and molecular mecha-
nisms underlying the supraspinal structures have been
studied in animal models of nerve injury [12,13]. Never-
theless, the changes in cellular regulatory and signaling
processes within the hippocampus in neuropathic pain
induced by partial sciatic nerve ligation (PSNL) have
remained minimally explored.
Nerve injury affects synaptic plasticity and induces
changes in multiple neurotransmitters and the transmis-
sion of intracellular signaling, through which the expres-
sion or function of excitatory and inhibitory receptors is
altered [14,15]. Glutamate is a major excitatory neuro-
transmitter of the central nervous system, and recent
studies have investigated the potential roles of the gluta-
matergic system in the pathophysiology and treatment
of mood disorders [16,17]. Expression of NMDA recep-
tors (NMDARs) including the NR1, NR2A and NR2B
subunits in spinal dorsal root ganglion and primary
afferents is believed to be an important mechanism
underlying chronic neuropathic pain [18,19]. Mild noxious
heat stimuli under a neuropathic pain condition induced
by a peripheral nerve injury may increase the release
of glutamate and the number of phosphorylated-NR1-
positive cells in the cingulate cortex [20].
The objective of this study was to elucidate the cellular
and molecular mechanisms responsible for the perception
of pain and the development of neuropathic pain–induced
behavior by measuring the expression of hippocampal
glutamatergic receptors following a peripheral neuro-
pathic injury that induces a chronic pain state mimicking
the clinical neuropathic pain induced by nerve injury.
Methods
Animals
Male Sprague–Dawley rats from Central South University
Animal Services (Changsha, China) weighing 220–250 g
were used. The experimental protocol was approved by
the Animal Care and Use Committee of Central South
University and conformed to the National Institutes of
Health Guide for the Care and Use of Laboratory Animals.
All efforts were made to minimize the number of rats usedand their suffering. Animals were housed under controlled
temperature (23 ± 2°C), relative humidity (50 ± 10%), and
artificial lighting (lights on from 7 am until 7 pm) with
distilled water and food available ad libitum. A right partial
sciatic nerve ligation (PSNL) model was established ac-
cording to the method of Seltzer et al. [21] with some
modifications. Under anesthesia (injection by administra-
tion of a dose of 10% chloral hydrate, 40 mg/kg,intraperi-
toneal), approximately one half of the nerve was ligated
with an absorbable 6–0 braided silk suture tied loosely
around the right sciatic nerve at the middle point of the
long axis of the thigh. For the control group, the rats were
subjected to the same procedure without nerve ligation.
Different rats were used for different procedures so that
no animal experienced more than one session, and the rats
were randomly assigned to procedures as described below.
Nociceptive testing
To validate the neuropathic pain model, we used the
mechanical withdrawal threshold (MWT), a classic test
for mechanical allodynia and the most reliable parameter
to assess neuropathic pain after nerve injury [22,23].
Mechanical allodynia was assayed using nylon von Frey
filaments according to the “up-down” algorithm as
described in our previous studies [24,25]. Nociceptive
testing was performed 2 days before surgery to obtain
baseline data. Mechanical allodynia was determined at 7,
14, 21 and 28 days after PSNL (n = 8/ group). The test-
ing was performed by two investigators who were
blinded to the experimental treatment. Rats were placed
on wire mesh platforms in clear cylindrical plastic enclo-
sures, and after 20 minutes of acclimation, filaments were
applied to the center of the plantar surface of the hind
paw and left in place for 5 s. Withdrawal of the hind paw
from the floor was scored as a response. When no re-
sponse was obtained, the next stiffer filament in the series
was applied to the same paw, if a response was obtained, a
less stiff filament was applied further. Testing proceeded
in this manner until four fibers had been applied after the
first one to cause a withdrawal response, allowing estima-
tion of the mechanical withdrawal threshold.
Elevated plus-maze test
Anxiety-like behavior was evaluated using the elevated
plus-maze (EPM) test as described in our previous studies
at 28 days after PSNL [24-27]. Briefly, after habituation for
approximately 1 day in the experimental room, rats were
placed in the middle of the EPM apparatus, and their
behavior was recorded by a video camera for 5 min.
Data were expressed as the percentage of time spent in
the open-arms as an index of anxiety-like behavior. The
number of open arm and closed-arm entries was calcu-
lated during the testing session. The maze was cleaned
after each trial.
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The open field test (OFT) was applied as described pre-
viously to assess anxiety-like behavior in the experimen-
tal animals at 28 day after PSNL [24-27]. Briefly, animals
were placed directly into the center of the open field
(100 × 100 × 48 cm, length × width × height) which was
divided equally into 25 squares. Movement of each
animal in the area was recorded during the 5-min testing
session. An observer blinded to the experimental condi-
tions coded the videotapes. The time spent in the center
of the open field were calculated. A greater amount of
time spent in the center of the nine squares indicated a
lower level of anxiety. Overall locomotor activity was
defined as the total number of squares crossed during
the testing session.
Forced swimming test
The forced swimming test (FST) is used often as an
animal model for assessing depression-like behavior. The
experiments in this study were carried out as described
in our previous study at 28 days after PSNL [28]. Briefly,
the rats were placed individually in a glass cylinder
(40 × 18 cm, height × diameter) containing water up to
30 cm at 23°C. After 15 min, they were returned to a 30°C
drying environment (the pre-test). Twenty-four hours
later, the rats were returned to the cylinder for 5 min
(the test), and this session was recorded with a video
camera. Experiments were performed between 14:00
and 16:00 pm. An experimenter, who was blinded to the
animal treatments, observed the videotapes. The total
immobility time was recorded, and a rat was considered
immobile when floating and making only the necessary
movements to keep its head above the water surface.
Sucrose preference test
The sucrose preference test (SPT), a two-bottle choice
paradigm, was carried out according to the procedure
used in our previous study to estimate the depression-
like behavior at 28 days after PSNL [28]. Briefly, the rats
were free to choose a 2% sucrose solution or water for 2
consecutive days, and the positions of two bottles were
altered once during the test. The consumption of water
and sucrose solution was measured by volume. The pref-
erence for 2% sucrose was calculated from the average
solution consumption in the 2 days and expressed as a
percentage of the total amount of liquid consumed.
Immunohistochemistry
At 28 days after PSNL, one set of rats (n = 4 or 6 for
each group) was sacrificed by an overdose of chloral
hydrate (80 mg/kg). Immunohistochemical staining for
GluR1, GluR2, NR1, NR2A, NR2B, and p-ERK1/2 was
performed as described in previous studies [15,29-31]
with a slight modification. Briefly, brains were fixed for4 h in 4% paraformaldehyde after perfusion and cryopro-
tection by immersion in 20% sucrose in phosphate buffer
(pH = 7.4) overnight. Transverse sections of the brain
(30 μm) were cut using a cryostat and mounted on
3-aminopropyl triethoxy- silane- coated slides. As de-
scribed in our prior studies but with some modifications
[31], 15 slices of hippocampus were randomly obtained
from eight sets of serial slices from each rat at – 2.3 mm
to – 5.8 mm anteroposterior to the bregma for immu-
nostaining. Rabbit anti-NR1 (1:1000; Epitomics, USA,
catalog number: 8173–1), NR2A (1:1000; Epitomics,
USA, catalog number: 3916–1), NR2B (1:1000; Abcam,
USA, catalog number: ab81271), GluR1 (1:500; Epi-
tomics, USA, catalog number: 3861–1), GluR2 (1:1000;
Epitomics, USA, catalog number: 3520–1), and p-ERK1/
2 (1:1000; Cell Signaling Technology, USA, catalog num-
ber: 4695) were incubated at 4°C overnight. The sections
were washed with 0.1% Triton X-100 solution in 0.1 M
phosphate-buffered saline (PBS) and further incubated
with the VECTASTAIN ABC Kit (Vector Laboratories,
USA, catalog number: PK- 4001), which contained bio-
tinylated goat anti-rabbit IgG secondary antibody (1:500)
and concentrated A and B reagents. Diaminobenzidine
tetrahydrochloride (DAB, Sigma, USA, 1:2000, catalog
number: D5905) was used as a peroxidase substrate. The
average optic density (OD) of positive staining was de-
tected in regions of CA1, CA2 and CA3 at the same
magnification factor and light intensity by an author
who was blinded to treatments using HPIAS-1000 image
analysis as described in previous studies [25,31,32]. Data
were acquired for 15 sections/brain region/animal and
averaged to produce a single value per animal.
Western blotting
Semi-quantified Western blotting was used to assess the
expression of GluR1, GluR2, NR1, NR2A and NR2B in
the ipsilateral hippocampus and performed as described
for our recent study [27,33] with a slight modification.
Another set of rats (n = 8 for each group) was sacrificed
under deep anesthesia. The hippocampus was removed
and immediately placed on dry ice and stored at −80°C
until use. Frozen samples were homogenized in a lysis
buffer containing protease inhibitors cocktails (Roche,
Germany, catalog number: P8340) and phenylmethane-
sulfonylfluoride (PMSF, Sigma, USA, catalog number:
p7626). Samples were then centrifuged at 10,000 rpm
for 15 min at 4°C, and the supernatants were used for
Western blotting.
Equal amounts of protein were loaded, separated by
10% Tris-Tricine sodium dodecyl sulfate polyacrylamide
gel electrophoresis, and then transferred onto a polyvini-
lidene difluoride membrane (Amersham Bioscience).
After blocking in 10% non-fat milk for 2 h at room
temperature, the membrane was incubated overnight at
Figure 1 Changes in MWT over time in rats after partial sciatic
nerve ligation. *** p <0 .001 represents statistically significant
differences compared with control group (n = 8/ group). PSNL
represents the partial sciatic nerve ligation group. MWT represents
mechanical withdrawal threshold.
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log number: 8173–1), NR2A (1:5000; Epitomics, USA,
catalog number: 3916–1), NR2B (1:3000; Abcam, USA,
catalog number: ab81271), GluR1 (1:3000; Epitomics,
USA, catalog number: 3861–1), GluR2 (1:5000; Epi-
tomics, USA, catalog number: 3520–1), p-ERK1/2
(1:2000; Cell Signaling Technology, USA, catalog num-
ber: 4695), and mouse anti-glyceraldehyde-3-phosphate
dehydrogenase (GAPDH; 1:2000, Millipore, USA, catalog
number: CB1001) primary antibodies. The blots were
then incubated with the second antibody, goat anti-
rabbit IgG conjugated with horseradish peroxidase
(1:2000, Pierce, Rockford, IL, catalog number: AB501-
01A) and goat anti-mouse IgG conjugated with horse-
radish peroxidase (1:2000, Pierce, Rockford, IL, catalog
number: AB503-01A) at room temperature for 2 h.
Membranes were washed three times with 0.02 M Tris-
buffered saline/Tween 20 (TBST) and signals were de-
tected by enhanced chemiluminescence (ECL, ComWin
Biotech Co, Beijing, China, catalog number: cw 0048c)
followed by exposure to X-ray films. For the quantifica-
tion of Western blot signals, X- ray films with blotting
bands were scanned. The BIORAD Image Analysis Sys-
tem (Bio-Rad Laboratories, Inc., Hercules, CA) was then
used to measure the integrated OD of the bands.
Effects of D-serine on the neuropathic pain-related
behavior induced by PSNL
To confirm the role of NMDARs in the anxiety-like be-
havior, we examined whether treatment with a co-
agonist of NMDAR could correct behavioral abnormal-
ities in rats after PSNL. D-serine (Sigma-Aldrich, St.
Louis, MO, USA, catalog number: s4250) was dissolved
in 0.9% saline. The solutions were prepared immediately
prior to the experiment. We injected D-serine (1 g/kg)
according to a protocol used in a previous study [34]
with some modifications. Animals from the control
groups received intraperitoneal injections of saline (ve-
hicle). Rats were subjected to OFT, EPM and nociceptive
testing individually 90 min after D-serine or saline
treatment.
Data and statistical analysis
Statistical analysis was performed using Graphpad Prism
5 (Graphpad Software, San Diego, CA). All results are
expressed as mean ± standard error (SEM). Differences
between groups were compared two-way analysis of
variance (ANOVA) followed by Bonferroni testing where
appropriate. For Western blot analysis, the protein ex-
pression in the control group was normalized to 1, and
the relative density of the other groups was calculated
proportionately. An unpaired two-tailed Student’s t test
was used if only two groups were applied. A p value
<0.05 was considered to indicate a significant difference.Results
PSNL causes behavioral changes related to neuropathic
pain
The persistence of nerve injury-induced hypersensitivity
to mechanical stimuli was assessed using nylon von Frey
filaments. Consistent with previous findings [21], the
MWT was lower 7 days after operation in the PSNL
group (2.42 ± 0.62 g) than in the control rats (10.55 ±
0.90 g; n = 8 for each group, p < 0.001, Figure 1). The
MWT in PSNL rats remained significantly lower (p <
0.001) than that in control rats at all other time points
examined (Figure 1).
PSNL induces anxiety-like but not depressive-like
behavior at 28 days after injury
Here, we carried out the OFT and EPM test to assess
the anxiety-like behavior in the two groups at 28 days
after operation. No significant difference was observed
in the total number of squares crossed in the open field
test between the PSNL and control rats (106.6 ± 11.33
vs. 99.67 ± 12.58, t = 0.4069, p > 0.05, n = 8 for control
and n = 9 for PSNL), although rats in the PSNL group
showed tended to exhibit a reduced travel distance com-
pared to the control rats (data not shown). We found
that PSNL was effective for inducing anxiety-like behav-
ior. Student’s t-tests indicated that the time spent in
the center of the open field was decreased significantly
(5.63 ± 0.96% vs. 2.96 ± 0.66%, t = 2.332, p < 0.05, n = 8
for control and n = 9 for PSNL, Figure 2A). In the EPM
test, the time spent in the open arm by the PSNL rats
was less than that by the control rats (9.68 ± 1.53% vs.
4.81 ± 0.94%, t = 2.610, p < 0.05, n = 8 for control and n = 7
Figure 2 Development of anxiety-like behavior but not depression-like behavior following PSNL. (A) Open-field test shows the decrease
in the amount of time spent in the central zone after injury (n = 8 for control and n = 9 for PSNL); (B) the percentage of time spent in the open
arm as detected by the EPM test in the control and PSNL groups (n = 8 for control and n = 7 for PSNL); (C) the percentage of preference for
sucrose in the sucrose preference test (n = 8 for control and n = 7 for PSNL); (D) immobility time in the forced swimming test (n = 7 for control
and n = 9 for PSNL), * p < 0.05 represents statistically significant differences compared with control group.
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in the total number of entries in the EPM test between the
two groups (8.63 ± 0.73 vs. 9.00 ± 1.02, t = 0.3040, n = 8 for
control and n = 7 for PSNL, p > 0.05, data not shown).
Then, we used the SPT to assess depression-like be-
havior. No difference was observed in the preference for
sucrose between the two groups (93.05 ± 1.21% vs. 89.02
± 1.75%, t = 1.935, p > 0.05, n = 8 for control and n = 7
for PSNL, Figure 2C). We also evaluated the depression-
like behavior at 28 days after ligation with the FST. Con-
sistently, there was no difference in the immobility time
between the two groups at this time point in the FST
(58.90 ± 3.84% vs. 68.56 ± 2.90%, t = 2.047, p > 0.05, n = 7
for control and n = 9 for PSNL, Figure 2D). These results
indicate that PSNL did not induce a depression-like be-
havior at 28 days post operation.
PSNL alters the expression of NMDA and AMPA receptors
in the hippocampus
Western blot and immunohistochemistry analysis were
conducted to assess the expression of NMDA and
AMPA receptors in the hippocampus at 28 days after
ligation. The expression of NMDARs and AMPARs inthe bilateral hippocampus was significantly altered, We
only presented the results for the expression of gluta-
matergic receptors in the ipsilateral hippocampus. Our
results showed that PSNL induced a decrease in NR1
expression (0.385 ± 0.026 vs.1.000 ± 0.029, t = 15.89, p <
0.001, n = 8 for each group, Figure 3) and NR2B (0.591 ±
0.039 vs. 1.000 ± 0.076, t = 4.818, p < 0.001, n = 8 for each
group, Figure 3) at the protein level in the ipsilateral
hippocampus of PSNL rats relative to expression levels
in the control rats. However, no significant difference in
the expression of NR2A (0.781 ± 0.108 vs. 1.000 ± 0.113,
t = 1.408, n = 8 for each group, p > 0.05), GluR1 (0.833 ±
0.073 vs. 1.000 ± 0.073, t = 1.657, n = 8 for each group,
p > 0.05), or GluR2 (0.882 ± 0.068 vs. 1.000 ± 0.091, t =
1.035, n = 8 for each group, p > 0.05) at the protein level
was observed between the two groups at postoperative
28 days. Meanwhile, we assessed the expression of NR1
and NR2B in the hippocampus with immunohistochem-
istry and observed that the expression of NR1 and NR2B
was significantly altered in the hippocampus (Figure 4 A-
P). Figure 4 shows the positive immunostaining for NR1
(A and E) and NR2B (I and M) in the cytoplasm and
process of neurons of the ipsilateral hippocampus of the
Figure 3 Effect of partial sciatic nerve ligation on glutamatergic receptors expression in the ipsilateral hippocampus. (A) GluR1 (MW= 106 kDa),
GluR2 (MW= 106 kDa), NR1 (MW= 120 kDa), NR2A (MW= 170 kDa) and NR2B (MW= 180 kDa) expression in the ipsilateral hippocampus using GAPDH
(MW= 36 kDa) as the loading control. (B) The densitometric analysis for GluR1, GluR2, NR1, NR2A and NR2B. n = 8 for each group, ***p < 0.001 represents
statistically significant differences compared with control group. MW represents molecular weight.
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analysis revealed that there were significant differences in
the OD for NR1 (Figure 4Q, CA1: 35.04 ± 3.42 vs 60.09 ±
1.66., t = 5.851, p < 0.01; CA2: 41.91 ± 3.41 vs.60.60 ± 4.19,
t = 3.459, p < 0.01; CA3: 35.34 ± 1.58 vs. 60.92 ± 4.22,
t = 6.222, p < 0.001, n = 6 for each group) and NR2B
(Figure 4R, CA1: 30.26 ± 3.24 vs. 62.66 ± 7.66, t = 3.897,
p < 0.01; CA2: 24.78 ± 2.07 vs.42.35 ± 2.73, t = 5.133 p <
0.01; CA3: 34.06 ± 2.24 vs. 46.17 ± 4.61, t = 2.364, p < 0.05,
n = 6 for each group) and positive staining in the ipsilateral
CA1, CA2, and CA3 regions of the hippocampus in the
two groups at postoperative 28 days. These results indicate
that PSNL can alter the expression of NR1 and NR2B in
the hippocampus.
PSNL decreases phosphorylation of p-ERK1/2 in the
hippocampus
To understand the mechanisms underlying glutamatergic-
mediated pain-related affective behavior, the glutamatergic-
dependent signaling pathways must be identified. We
postulated that PSNL could affect the phosphorylation
of ERK1/2 in the hippocampus. As shown in Figure 5A,
Western blot was conducted to confirm the expression
of p-ERK1/2 in the ipsilateral hippocampus at 28 days
after ligation. The results showed that the level of
p-ERK 1/2 was significantly reduced (0.59 ± 0.08 vs.1.00
± 0.07, t = 3.801, p < 0.01,n = 8 for each group, Figure 5B).
There was no significant difference in total ERK1/2
expression at 28 days between the two groups (data not
shown). Immunoreactivity for p-ERK1/2 was exhibited in
the pyramidal-shaped neurons and in the processes of
neurons in the CA1, CA2, and CA3 regions of the ipsilat-
eral ventral hippocampus of the control (Figure 6 A-D)
and PSNL groups (Figure 6 E-H). Student’s t tests analysis
revealed that the OD level for p-ERK1/2 immunostaining
at the different regions of the hippocampus in the PSNLgroup was less than that in the control group (Figure 6I,
CA1: 32.59 ± 2.05 vs. 44.80 ± 1.82, t = 4.452, p < 0.01; CA2:
19.31 ± 0.79 vs. 29.12 ± 1.83, t = 4.915 p < 0.01; CA3: 18.80
± 1.38 vs. 23.95 ± 0.99, t = 3.031, p < 0.05, n = 4 for each
group) at 28 days after ligation.
D-serine reduces the PSNL-induced anxiety-like behavior
but not nociceptive pain
To further determine the role of NMDAs in the neuro-
pathic pain-related behavior induced by PSNL, D-serine
was administered intraperitoneally at postoperative day
28. After 90 min of injection, animal behaviors were
examined. As shown in Figure 7A, nerve injury affected
the values of MWT (F(3,25) = 79.96, p < 0.001), however,
there was no main effect of drug treatment (F(1,25) =1.376,
p > 0.05) and their interaction (F(3,25) =2.331, p > 0.05) on
MWT. Two-way ANOVA indicated nerve injury (F(1, 23) =
7.450, p < 0.05), and drug treatment (F(1,23) = 5.997, p <
0.05) all affected the percentage of the time spent in the
open arm detected by the EPM test. However, no main
effect of their interaction (F(1,23) =3.348, p > 0.05) was
observed on the percentage of the time spent in the
open arm (Figure 7B). Bonferroni post-tests showed
that the time spent in the open arm by the PSNL group
after vehicle treatment was less than that by other
groups (p < 0.05). Two-way ANOVA indicated nerve
injury (F(1,23) = 7.873, p < 0.05), and drug treatment
(F(1,23) = 4.831, p < 0.05) affected the time in the central
zone detected by the OFT. However, no main effect of
their interaction (F(1,23) = 0.8951, p > 0.05) was observed
on the time in the central zone (Figure 7C). Bonferroni
post-tests showed that the time spent in the central
zone by the PSNL group after vehicle treatment was less
than that by other groups (p < 0.05). There was no main
effect of nerve injury (F(1,25) = 0.3706, p > 0.05) and drug
treatment (F(1,25) = 0.02965, p > 0.05) and nor their
Figure 4 (See legend on next page.)
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Figure 4 Effect of partial sciatic nerve ligation on NR1 and NR2B the ipsilateral ventral hippocampus. Representative coronal sections
stained for NR1 (A and E) and NR2B (I and M) in specimens from the control (A, I) and PSNL groups (E, M). The higher magnification images of
NR1 and NR2B staining in CA1, CA2, and CA3 of the ipsilateral hippocampus are displayed for the control (B, C, D) and PSNL group (F, G, H);
Those for the control (J, K, L) and PSNL groups (N, O, P) respectively, correspond to the labeled regions in A, E, I, and M. Scale bar: 100 μm in P;
400 μm in M. (Q and R) Quantitative analysis of OD for NR1 and NR2B in ipsilateral sides of CA1, CA2, and CA3 of the whole hippocampus for
each group. n = 6 for each group, ***p < 0.001,**p < 0.01,*p < 0.05 represents statistically significant differences compared with control group.
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ber of squares crossed (Figure 7D). These data imply
that the activation of NMDAs only contributes to the
expression of pain-related anxiety but not mechanical
hypersensitivity induced by nerve ligation.
Discussion
Peripheral nerve injury results in chronic neuropathic
pain characterized by allodynia and/or affective aversive
disturbances that are detrimental to patients’ well being
and ability to function [3,35]. In the current study, we
investigated the impact of PSNL on anxiety-like and
depression-like behaviors in rats and the potential under-
lying molecular alterations in the hippocampus at
28 days after injury, and provided a possible explanation
for behaviors related to chronic pain. We chose the time
point of 28 days because early time points might not
fully assimilate the impact of chronic pain on central
nervous system plasticity and the development ofFigure 5 Effect of partial sciatic nerve ligation on p-ERK1/2
(MW= 44/42 kDa) expression in the ipsilateral hippocampus.
(A) Representative bands are shown for two groups, using GAPDH
(MW= 36 kDa) as the loading control; (B) densitometric analysis
for p-ERK1/2 in the control and PSNL groups. n = 8 for each group,
**p < 0.01 represents statistically significant differences compared
with control group.co-morbid conditions, such as anxiety-like behavior in
rats which can take more than 10 days to develop after
ligation of the lumbar 5 spinal nerve [36]. More import-
antly, there were no alterations in anxiety-like behavior
and depression-like behavior at early time points after
injury (data not shown) in the current study. The results
of our study showed that the anxiety-like behavior de-
velops after PSNL as a typical feature of the neuropathic
pain model in addition to the development of mechan-
ical hypersensitivity. OFT results showed that the time
spent in the central zone was significantly reduced at
28 days after injury. Moreover, this decrease did not
result from a pain-evoked reduction in locomotion as in
the travel distance between the two groups did not
differ (data not shown). In addition, in the EPM test,
rats of the PSNL group spent significantly less time in
the open arms than did control rats. These data demon-
strate that the anxiety-like behavior develops after in-
jury, as seen in models of chronic inflammatory pain
[37], incisional pain [24,25] and visceral pain [26].
Unexpectedly, we failed to observe any depression-like
behavior at 28 days after surgery which is inconsistent
with a previous report that PSNL caused a significant
depression-like behavior in mice at the 4th week after
surgery [38]. This discrepancy could be partially ex-
plained by the use of different species in the two studies.
Although the previous study suggested that depression-
related behavior was observed 6–8 weeks after insertion
of a polyethylene cuff around the main branch of the
right sciatic nerve in C57BL/6 J mice [39], an approach
different that used in the present study, we inferred that
the discrepancies in the results may be related to differ-
ences in the experimental time period (28 days vs. 6–8
weeks), the model (PSNL vs. inserting a polyethylene
cuff around the main branch of the right sciatic nerve),
or the species (rat vs. C57BL/6 J mice). Nevertheless, we
can not preclude that there is a possibility of the devel-
opment of depression-like behavior in the longer term
after PSNL.
The increases in the incidence and prevalence of nerve
injury-related mood disorders highlight the need for a
more comprehensive understanding of the molecular
mechanisms responsible for these behavioral changes.
Accumulating evidence indicates that chronic neuro-
pathic pain remains difficult to manage and causes gross
reorganization and function in both cortical and subcortical
Figure 6 Representative photomicrographs show p-ERK1/2 immunoreactivity in the CA1, CA2, and CA3 regions of the ipsilateral
ventral hippocampus from coronal brain sections between the control (A) and PSNL groups (E). B, C, D and F, G, H are the higher
magnification images corresponding to the labeled regions in A and E respectively. (I) Quantitative analysis of the OD of p-ERK1/2 in ipsilateral
sides of the CA1, CA2, and CA3 regions of the whole hippocampus for each group. Scale bar: 100 μm in H; 400 μm in E. n = 4 for each group,
**p < 0.01, *p < 0.05 PSNL vs control.
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structure associated with many chronic pain conditions
is involved in abnormal sensitivity to neuropathic pain
[9,13]. Previous studies have shown that rats with per-
ipheral nerve injury showed changes in network activity
related to the hippocampus in addition to behavioral
manifestations [42,43]. The hippocampus was chosen
based on evidence that the hippocampus and other lim-
bic regions are structures responsible for regulating the
emotional component, modulating the transmission of
noxious pain, and processing painful stimuli [44].
Abnormal activity of glutamatergic synapses has been
regarded as a mechanism in the development of neuro-
pathic pain [45]. A recent study showed that the phos-
phorylation of NR1 is significantly increased in the
ipsilateral dorsal horn of PSNL rats, suggesting that NR1
phosphorylation is involved in the signals underlyingneuropathy [18]. A key and novel finding of this study is
that NR1 and NR2B expression levels are reduced in the
bilateral hippocampi, particularly in the ventral hippo-
campus which is not required for anxiety-like behavior
like its dorsal counterpart [46]. In contrast, the expres-
sion of NR2A was not altered in PSNL rats. In humans
with bipolar disorders, the expression of NR1 and NR2A
transcripts in the hippocampal tissue is reduced, but
there is no change in NR2B expression [47]. An earlier
report showed the NR1 transcript expression is reduced in
the hippocampus of mood disorders [48]. Nevertheless,
these studies point to a conclusion of abnormal expression
of NMDAR in affective disorders. The significance of
altered expression of NR1 and NR2B expression in the
hippocampus in the neuropathic pain and related be-
havior induced by PSNL is not clear. Activation of
NMDARs with D-serine in the rostral ACC is required
Figure 7 Effect of D-serine on mechanical nociceptive threshold and anxiety-like behavior at 28 days after PSNL. Ninety minutes after
D-serine treatment, MWT (A), EPM (B), and OFT (C and D) were examined. The decreased MWT induced by PSNL was not attenuated by
D-serine treatment (A). The percentage of time spent in the open arm as detected by the EPM test among the different groups (B). The percentage
of time spent in the central zone as detected by the OFT among the different groups (C). The total number of squares crossed in the open field
(D). *P <0.05 PSNL + Vehicle compared with Control + Vehicle, Control + D-serine and PSNL + D-serine groups. ***p < 0.001 PSNL + Vehicle and
PSNL+ D-serine compared with Control + Vehicle and Control + D-serine groups.
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negative emotion [49]. We found that D-serine treat-
ment exhibits anxiolytic-like activity in the OPT and
EPM tests without altering locomotive activity, suggest-
ing that NMDAR plays a role in the PSNL induced
pain-related negative emotions. However, D-serine did
not affect mechanical hypersensitivity after PSNL, which
is similar to the result for formalin-induced pain behavior
following intrathecal administration of D-serine [50].
AMPA receptors are usually co-expressed with NMDARs
at mature synapses, are responsible for the initial reaction
to glutamate in the synapse and play distinct roles in
different neuropathic pain models [51-53]. We noticed
that there was no alteration of GluR1 or GluR2 expres-
sion in the hippocampus in our model. In other studies,
increased GluR1 and GluR2 levels were found in spinal
cord after sciatic nerve ligation [54]. In contrast, neither
GluR1 nor pGluR1 is changed in the rat spinal dorsal
horn after L5 spinal nerve ligation [55]. The GluR2 and
GluR3 subunits of AMPA receptor are implicated in the
trigeminal nerve injury-mediated hyperalgesia [56]. One
possibility for these differences in study findings could
be due to the use of different models and/or different
locations studied.
Increasing evidence shows that mitogen-activated pro-
tein kinases such as ERK in the ACC and dorsal horn
play important roles in the generation of both acute painsuch as surgical pain and visceral pain, as well as chronic
pain [24,26,57-59]. Accumulating evidence indicates that
the maintenance of the sensory and affective components
of the pain state are differentially regulated [60,61]. As
most clinical neuropathic pain is chronic, it is important
to address the activation of ERK1/2 at longer time points.
Persistent pain was also believed to induce the synaptic
plasticity in the supraspinal areas, and deactivating or acti-
vating ERK in these regions would affect the nocifensive
and affective pain [62,63]. Seo et al. indicated that
supraspinal phosphorylated (p)-ERK1/2 in the hippocam-
pus has an important role in nociception and antinocicep-
tion that may be downstream pathways of NMDAR
activity [64]. NMDARs can activate the ERK/CREB signal-
ing pathway in the rACC which is believed to mediate the
pain-related negative emotion [65]. Therefore, ERK was
selected as a potential substrate in the interaction between
pain and mood in the present study. Our study demon-
strated decreased phosphorylation of ERK in the hippo-
campus after PSNL. These results indicate the possibility
that supraspinal p-ERK1/2 could play a vital role in the
pathogenesis of neuropathic pain.
Conclusion
Peripheral nerve injury causes chronic mechanical allo-
dynia and is accompanied by anxiety-like behavior. The
expression of hippocampal glutamatergic receptors and
Wang et al. BMC Neuroscience  (2015) 16:14 Page 11 of 12ERK phosphorylation is altered after nerve ligation, dis-
playing an association between NMDAR and the
anxiety-like behavior. Whether the decreased phosphor-
ylation of ERK contributes to the anxiety-like behavior
after ligation warrants further studies. Further molecu-
lar and neurochemical analyses are needed to elucidate
the exact mechanisms of affective dimensions of pain.
Our findings shed light on the possible role of hippo-
campal NMDARs in the pain and anxiety-like behavior
induced by PSNL. These results suggest an effective
strategy for developing novel drugs targeting NMDARs
in the treatment of anxiety-like disorders in neuropathic
pain in clinics.
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